Surendra Hanumanthaiah Honnamachanahalli

Surendra Hanumanthaiah Honnamachanahalli

Director Director DIN 03168250
DIN 03168250 First appointment Aug 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Aug 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Surendra Hanumanthaiah Honnamachanahalli

Data last updated:

Surendra Hanumanthaiah Honnamachanahalli was a Director at Belaku Eye Hospitals Private Limited (2010–2018). The company operates in Healthcare.

DIN 03168250
Primary Designation Director
Industry Healthcare
First Appointment 16 Aug 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Belaku Eye Hospitals Private Limited U85110KA2010PTC054798
Director16 Aug 20102010₹6.26 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Belaku Eye Hospitals Private Limited
Premium access

Shareholding and investment profile for Surendra Hanumanthaiah Honnamachanahalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Hanumanthaiah Honnamachanahalli

Surendra Hanumanthaiah Honnamachanahalli was first appointed on 16 Aug 2010 as Director at Belaku Eye Hospitals Private Limited.

Surendra Hanumanthaiah Honnamachanahalli held 1 earlier board appointment: Belaku Eye Hospitals Private Limited (Director, 16 Aug 2010 to 30 Sep 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available